Ovintiv price target raised to $67 from $65 at Morgan Stanley
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Target raised to $67; posted price $65.69 by Morgan Stanley.
Target: $67
Posted price: $65.69
Analyst firm: Morgan Stanley
Analyst: Devin McDermott
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.